N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis

• DOI: 10.1016/j.gendis.2022.02.014
• Publication Date: 2022-03-26T23:24:15Z
• Authors: Wan-Xin Peng; Fei Liu; Jia-Hong Jiang; Hang Yuan; Ziqiang Zhang; Liu Yang; Yin-Yuan Mo
• Keywords: 0301 basic medicine; Medicine (General); IGF2BP2; PDAC; MYC; QH426-470; 3. Good health; LINC00901; 03 medical and health sciences; R5-920; YTHDF1; Full Length Article; Genetics; N6-methyladenosine modification (m6A)

Accumulating evidence indicates that RNA methylation at N